耳鼻喉科Pubmed文献追踪每日 14:00 同步
← 返回全部文献
Article record

一种分子,不同回路?肉毒毒素关于颅颈共病能揭示与不能揭示的内容

One Molecule, Different Circuits? What Botulinum Toxin Can and Cannot Reveal About Craniocervical Comorbidity.

综述 Meta耳科IF 4.7Q2

文献信息

中文摘要

背景: A型肉毒神经毒素(BoNT-A)被用于共存的颅颈疾病,治疗反应常被过度解读为存在共同发生器的证据。磨牙症文献说明了原因。在六项采用事件级结局测量的对照研究中,报告的事件频率效应并不取决于剂量或注射区域,而取决于用于检测事件的规则能否跟随毒素刚刚降低的振幅;目前尚无研究将安慰剂组与不依赖振幅的事件定义相结合。本靶向批判性叙述性综述从机制角度解读代表性证据,而非评估疗效。它考察慢性偏头痛、紧张型头痛、肌源性颞下颌关节紊乱和磨牙症,并以躯体感觉性耳鸣作为跨模态边界案例。慢性偏头痛的疗效具有方案特异性,其他情况则不确定。示踪研究定位了脊髓三叉神经核和背柱核中通往耳蜗核的躯体感觉通路;在所综述的示踪文献中,尚未证明存在从三叉神经中脑核直接到耳蜗的投射,因此躯体-听觉的合理性并不能确立肌肉靶向理由所援引的咀嚼肌本体感觉通路。由于BoNT-A影响运动输出、外周伤害性信号和肌梭输入——最后一项在不同注射区域的可及性可能不同——我们将其框定为一种部位依赖的多输出扰动。该药理学已确立;本文提供的是推断框架及由此得出的解剖学约束。

英文摘要

Botulinum neurotoxin type A (BoNT-A) is used across coexisting craniocervical conditions, and therapeutic response is often overinterpreted as evidence of a shared generator. The bruxism literature shows why. Across six controlled studies with event-level outcome measurement, reported effects on event frequency track not dose or injection field but whether the rule used to detect an event could follow the amplitude the toxin had just reduced; none yet combines a placebo arm with an amplitude-independent event definition. This targeted critical narrative review interprets representative evidence mechanistically rather than assessing efficacy. It examines chronic migraine, tension-type headache, myogenous temporomandibular disorders, and bruxism, with somatosensory tinnitus as a cross-modal boundary case. Efficacy is protocol-specific in chronic migraine and uncertain elsewhere. Tracing studies locate somatosensory routes to the cochlear nucleus in the spinal trigeminal and dorsal column nuclei; a direct mesencephalic-trigeminal-to-cochlear projection has not been demonstrated in the tracing literature reviewed, so somatic-auditory plausibility does not establish the masticatory proprioceptive route invoked by muscle-targeted rationales. Because BoNT-A affects motor output, peripheral nociceptive signaling, and muscle spindle input-the last of these probably differing in availability across injection fields-we frame it as a site-dependent, multi-output perturbation. That pharmacology is established; what is offered here is the inferential framing and the anatomical constraint following from it.